Skip to main content

Peer Review reports

From: Assessment of the treating physicians’ first-hand experience with handling and satisfaction of ofatumumab therapy: findings from the PERITIA survey conducted in Europe

Original Submission
28 Feb 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
9 Apr 2022 Reviewed Reviewer Report
7 May 2022 Reviewed Reviewer Report - Francesco Crescenzo
24 May 2022 Author responded Author comments - Daniela Rau
Resubmission - Version 3
24 May 2022 Submitted Manuscript version 3
26 May 2022 Author responded Author comments - Daniela Rau
Resubmission - Version 4
26 May 2022 Submitted Manuscript version 4
2 Jun 2022 Reviewed Reviewer Report - Francesco Crescenzo
6 Jun 2022 Reviewed Reviewer Report
20 Jun 2022 Author responded Author comments - Daniela Rau
Resubmission - Version 5
20 Jun 2022 Submitted Manuscript version 5
2 Aug 2022 Author responded Author comments - Daniela Rau
Resubmission - Version 6
2 Aug 2022 Submitted Manuscript version 6
19 Oct 2022 Author responded Author comments - Daniela Rau
Resubmission - Version 7
19 Oct 2022 Submitted Manuscript version 7
15 Mar 2023 Author responded Author comments - Daniela Rau
Resubmission - Version 8
15 Mar 2023 Submitted Manuscript version 8
25 Mar 2023 Reviewed Reviewer Report
Resubmission - Version 9
Submitted Manuscript version 9
Publishing
28 Mar 2023 Editorially accepted
10 Apr 2023 Article published 10.1186/s12883-023-03190-x

You can find further information about peer review here.

Back to article page